Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
279.9 USD | 0.00% | 0.00% | -12.71% |
08/05 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
08/05 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
Chart calendar Bio-Rad Laboratories, Inc.
Upcoming events on Bio-Rad Laboratories, Inc.
Past events on Bio-Rad Laboratories, Inc.
08/05/2024 02:30 am | Q1 2024 Earnings Call |
08/05/2024 01:45 am | Q1 2024 Earnings Release |
24/04/2024 04:30 am | Annual General Meeting |
01/03/2024 01:00 am | Citi Unplugged Medtech and Life Sciences Access Day |
16/02/2024 03:30 am | Q4 2023 Earnings Call |
16/02/2024 02:45 am | Q4 2023 Earnings Release |
08/01/2024 | JPMorgan Healthcare Conference |
27/10/2023 02:30 am | Q3 2023 Earnings Call |
27/10/2023 01:45 am | Q3 2023 Earnings Release |
07/09/2023 08:30 pm | Wells Fargo Healthcare Conference |
04/08/2023 02:30 am | Q2 2023 Earnings Call |
04/08/2023 01:45 am | Q2 2023 Earnings Release |
09/06/2023 12:30 am | Jefferies Global Healthcare Conference |
18/05/2023 01:05 am | RBC Global Healthcare Conference |
05/05/2023 02:30 am | Q1 2023 Earnings Call |
05/05/2023 01:45 am | Q1 2023 Earnings Release |
26/04/2023 04:30 am | Annual General Meeting |
02/03/2023 10:15 pm | Citi Healthcare Services Medtech Tools & HCIT Conference |
17/02/2023 03:30 am | FY 2022 Earnings Call |
17/02/2023 02:35 am | FY 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 312 2 329 -0.73% | 2 546 2 430 4.76% | 2 923 2 893 1.04% | 2 802 2 816 -0.49% | 2 671 2 676 -0.18% | 2 661 |
EBITDA Million USD | Released Forecast Spread | 390 406 -4.12% | 537 522 2.96% | 677 678 -0.04% | 668 635 5.14% | 536 521 2.92% | 470 |
EBIT Million USD | Released Forecast Spread | 279 294 -5.39% | 427 403 5.8% | 571 598 -4.49% | 524 530 -1.09% | 379 383 -1.13% | 347 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 4 908 3 985 23.15% | 5 438 694 683.59% | 0,00 0,00 - | -850 503 -269.07% | 377 |
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | 3 806 3 087 23.3% | 4 246 541 684.82% | -3 628 -3 508 -3.42% | -637 392 -262.67% | 294 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | 126 102 23.37% | 141 17,9 683.94% | 0,00 0,00 - | -21,8 13,5 -262.11% | 10,3 |
Announcement Date | 13/02/20 | 11/02/21 | 10/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 700 677 3.48% | 691 674 2.6% | 681 683 -0.28% | 730 741 -1.45% | 677 689 -1.8% | 681 696 -2.12% | 632 692 -8.61% | 681 687 -0.79% | 611 620 -1.5% | 641 | 669 | 733 | 649 | 676 |
EBITDA Million USD | Released Forecast Spread | 179 138 30.25% | 156 135 16.12% | 132 140 -5.26% | 156 167 -6.51% | 149 151 -1.79% | 138 134 2.51% | 113 143 -21.03% | 137 136 0.61% | 109 91,3 18.86% | 93,0 | 119 | 155 | 114 | 122 |
EBIT Million USD | Released Forecast Spread | 154 109 41.6% | 130 106 23.09% | 106 111 -4.46% | 127 140 -9.16% | 84,2 122 -31.13% | 108 106 2.07% | 81,6 112 -27.14% | 105 107 -1.39% | 59,0 61,8 -4.48% | 64,9 | 88,8 | 122 | 82,7 | 91,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1 500 108 -1491.07% | |||||||||||||
Net income Million USD | Released Forecast Spread | 828 953 -13.17% | -1 162 83,6 -1490.39% | 350 | |||||||||||
EPS USD | Released Forecast Spread | -5,52 2,63 -309.89% | -39,6 2,81 -1508.9% | ||||||||||||
Announcement Date | 28/04/22 | 28/07/22 | 27/10/22 | 16/02/23 | 04/05/23 | 03/08/23 | 26/10/23 | 15/02/24 | 07/05/24 | - | - | - | - | - |
13/05/2024 | PARAMOUNT BED HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
14/05/2024 | HLB CO., LTD.: Q1 2024 Earnings Release (Projected) |
14/05/2024 | TERUMO CORPORATION: Q4 2023 Earnings Release |
14/05/2024 | ALFRESA HOLDINGS CORPORATION: Q4 2023 Earnings Release |
14/05/2024 10:30 am | AMBU A/S: Q2 2024 Earnings Release |
15/05/2024 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 | HOYA CORPORATION: Q4 2023 Earnings Release |
16/05/2024 11:30 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
22/05/2024 10:30 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
23/05/2024 04:15 pm | MEDTRONIC PLC: Q4 2024 Earnings Release |
Past sector events for Bio-Rad Laboratories, Inc.
11/05/2024 01:40 am | ATRION CORPORATION: Q1 2024 Earnings Release |
10/05/2024 | NIPRO CORPORATION: Q4 2023 Earnings Release |
10/05/2024 | PHC HOLDINGS CORPORATION: Q4 2023 Earnings Release |
10/05/2024 02:00 am | METTLER-TOLEDO INTERNATIONAL, INC.: Q1 2024 Earnings Release |
10/05/2024 01:33 am | BIOLIFE SOLUTIONS, INC.: Q1 2024 Earnings Release |
10/05/2024 01:31 am | INSULET CORPORATION: Q1 2024 Earnings Release |
09/05/2024 04:00 pm | STEVANATO GROUP S.P.A.: Q1 2024 Earnings Release |
09/05/2024 04:00 pm | EMBECTA CORP.: Q2 2024 Earnings Release |
09/05/2024 03:30 pm | HAEMONETICS CORPORATION: Q4 2024 Earnings Release |
09/05/2024 | POLY MEDICURE LIMITED: Q4 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIO Stock
- BIO.B Stock
- Calendar Bio-Rad Laboratories, Inc.